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Objectives: The objectives of this study were to determine the results of a specific technique in the performance of carotid
endarterectomy (CEA) and to compare results using this technique between standard-risk and high-risk patients eligible
for Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) and between
asymptomatic and symptomatic patients.
Methods: A total of 391 patients underwent 442 consecutive CEA procedures under general anesthesia with the intent to
shunt, patch, and perform intraoperative completion duplex ultrasound imaging. Indications included 272 asymptomatic
patients (61.5%) with carotid stenoses >60% and 170 symptomatic patients (38.5%) with carotid stenosis >50%. Data
were analyzed to determine the early (<30 days) and long-term morbidity and mortality overall in standard-risk and
high-risk procedures and in asymptomatic and symptomatic patients. The primary end points were the occurrence of all
strokes or death or myocardial infarction (MI) in the first 30 postoperative days (100% follow-up) and the occurrence by
life-table analysis of ipsilateral stroke or death or MI (SDMI) out to 93 months (mean, 31.4 months).
Results: A total of 441 (99.7%) procedures included shunting, 440 (99.5%) included patching, and 442 (100%) had
completion duplex ultrasound imaging. Of these, 235 procedures were standard risk and 207 procedures were high risk.
At the 30-day follow-up, there were two ipsilateral central neurologic deficits (1 major stroke, 1 minor stroke), no death,
and oneMI (0.45% for all strokes or death; 0.68% for all strokes or death orMI). After 30 days of follow-up, an additional
16 strokes (9 ipsilateral, 7 contralateral), eightMIs, and 38 deaths had occurred. No statistically significant difference was
found between standard-risk and high-risk groups or between asymptomatic and symptomatic groups for stroke, death,
MI, stroke or death, or stroke or death or MI at 30 days or during long-term follow-up at any interval up to 93 months.
Conclusion:CEAperformedwith intent to treat using general anesthesia, shunting, patching, and completion duplex scanning
results in extremely low 30-day and long-term morbidity and mortality in asymptomatic, symptomatic, standard-risk and
high-risk patients. These results are substantially superior to those reported in carotid stenting trials for both carotid stenting
and CEA and do not support the contention that there is a high-risk group for CEA. (J Vasc Surg 2007;46:876-82.)Carotid endarterectomy (CEA) has been shown to be
superior to medical therapy in the prevention of stroke in
symptomatic patients with internal carotid artery stenosis of
50% (North American Symptomatic Carotid Endarterec-
tomy Trial) and in asymptomatic patients with internal
carotid stenoses of 60% (Asymptomatic Carotid Athero-
sclerosis Study).1,2 It has been suggested that the good
results obtained from CEA in these trials might have been
due to the elimination of high-risk surgical patients and
that unselected patients might not fare as well from the
procedure.3 It has been further suggested that such high-
risk patients might form a subset of patients appropriate for
inclusion in carotid stenting studies. Almost all carotid
stent trials, including the studies mandated by United
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876States Food and Drug Administration after approval, have
limited the patient cohort to high-risk patients. In addition,
Medicare reimbursement has been approved only in high-
risk patients. However, the concept that such high-risk
patients experience more perioperative morbidity and mor-
tality with CEA has been challenged in several previous
studies.4-7
In most studies comparing CEA with carotid stenting,
the technique for the performance of carotid stenting and
the devices to be used were defined, but the technique for
CEA was the surgeon’s usual and customary approach.
Thus, several different techniques of CEA were likely in-
cluded in these studies. The current study was undertaken
to assess the results of a specific CEA technique, on an
intent-to-treat basis, in both high-risk and low-risk consec-
utive asymptomatic and symptomatic patients as defined in
Stenting and Angioplasty with Protection in Patients at
High Risk for Endarterectomy (SAPPHIRE), Table I.
METHODS
Patients. From April 1999 through June 2005, 391
patients having 442 consecutive elective CEAs in a single
institution private practice setting by four different vascular
surgeons were entered into a vascular registry. All CEAs
were done using a specific technique that included general
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completion duplex scanning. Indications included asymp-
tomatic patients with carotid stenosis of 60% and symp-
tomatic patients with carotid stenosis of 50%.
Patients underwent follow-up neurologic examinations
by a vascular surgeon 24 hours of the surgery and had
additional neurologic examinations at approximately 1 and
6weeks postoperatively.Myocardial infarction (MI) testing
was only performed for clinical symptoms. Postoperative
duplex ultrasound scans were performed at 6 weeks post-
operatively and every 6 months thereafter. Duplex criteria
for percentage of stenosis are included in the Appendix
Table I (available online only). Long-term follow-up was
performed at every 6-month office visit by a vascular sur-
geon.
Technique of carotid endarterectomy. A standard
vertical incision was used. The posterior auricular nerve was
avoided whenever possible, and retraction against the jaw
in the area where the marginal mandibular nerve courses
was minimized as much as possible. Meticulous technique
with minimal manipulation of the carotid artery was done
during dissection of the artery. Cranial nerves were avoided
but not purposely dissected out for identification. Heparin
(7500 U) was administered before arterial clamping.
The internal carotid artery was grasped and occluded
distal to the plaque with a DeBakey forceps and clamped
distal to the forceps with a Senning bulldog clamp before
any other arterial clamping was performed. The external
and then common carotid arteries were clamped. A Pruitt-
Inahara (LaMaitre Vascular, Burlington, Mass) T-shaped
shunt with a side arm with a stopcock was used. The shunt
was first inserted into the internal carotid artery and the
balloon inflated. Back bleeding from the internal carotid
was allowed to flush the shunt. The shunt was then clamped
on the internal carotid side of the T arm with a mosquito
hemostat, after which the other end of the shunt was
inserted into the common carotid artery and the balloon
was inflated. Forward bleeding was then allowed to occur
from the common carotid artery out the end of the T arm of
the shunt. The stopcock on the end of the T arm was then
closed and the mosquito hemostat removed, thus provid-
ing flow from the common carotid artery through the shunt
Table I. High-risk criteria and prevalence in this study*
Criteria† No.‡
Significant cardiac disease 15
Severe pulmonary disease 74
Contralateral carotid occlusion 17
Contralateral laryngeal nerve palsy 3
Previous radical neck surgery/radiation 2
Tracheostomy 2
Recurrent carotid stenosis 22
Age 80 years 105
*207 procedures.
†As defined in the Stenting and Angioplasty with Protection in Patients at
High Risk for Endarterectomy (SAPPHIRE) trial.3
‡Multiple criteria were present in some patients.into the internal carotid artery.A standard endarterectomy was then performed. The
proximal end of the plaque was transected with Potts
scissors. An eversion endarterectomy of the external carotid
artery was performed during temporary external carotid
artery clamp release. The internal carotid artery end point
was achieved either through a natural break point or was
created using a beaver blade scalpel. Tacking sutures were
not used. All intimal and medial tissue was removed with
the specimen. Copious heparinized flushing was performed
to clean the endarterectomized surface and to check for any
tissue flaps.
The arteriotomy was closed with a bovine pericardial
patch angioplasty with a continuous suture technique. Ar-
terial hypoplasia and redundancy were treated with bypass
and internal carotid artery segmental resection with patch,
respectively. The patch was always extended distal to the
distal end point of the endarterectomy in the internal
carotid artery.
The shunt was removed just before final patch closure.
Shunt removal was accomplished by first clamping themain
channel of the shunt on either side of the T arm. The
internal carotid balloon was deflated first, and the distal end
of the shunt was removed while allowing back bleeding
from the internal carotid artery. The internal carotid artery
was then reclamped. The common carotid artery was then
controlled with finger compression while the common
carotid artery balloon was deflated and the shunt was
removed. Forward bleeding was then allowed from the
common carotid artery, after which it was clamped. Back
bleeding was then allowed from the external carotid artery.
The artery was again flushed with heparinized saline. The
remaining patch opening was then closed, with back bleed-
ing from the internal carotid allowed just before the stitch
was tied to again flush the artery and to allow any air to
escape.
The proximal internal carotid artery was occluded with a
DeBakey forceps, and flow was first re-established from the
common carotid artery into the external carotid artery,
followed by removal of the DeBakey forceps and re-estab-
lishment of flow into the internal carotid artery.
After hemostasis was obtained, an intraoperative du-
plex ultrasound scan was performed. If the scan revealed
any defect the surgeon thought was significant, the artery
was reopened and the defect was corrected. Heparin was
routinely reversed with 50 mg of protamine. The wound
was closed over a drain placed to bulb suction.
Statistical analysis. Data were analyzed by procedure.
Procedures were divided into high-risk and standard-risk
groups as well as into symptomatic and asymptomatic
groups by preoperative surgical indication. High-risk pa-
tients were defined as those who met the definition of high
risk according to criteria used in the SAPPHIRE study
(Table I).3 Standard-risk patients included all the remain-
ing patients not included in the high-risk group.
Data were analyzed to determine early (30 days) and
late (30 days) morbidity and mortality overall and in each
risk group as well as for symptomatic vs asymptomatic
patients. The primary end points were the occurrence of all
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tive days (100% follow-up) and the occurrence of ipsilateral
stroke or death or MI (SDMI) out to 93 months (mean,
31.4 months).
Results were analyzed using standard statistical meth-
ods, including 2 test, the Fisher exact test, and Goodman-
Kruskal  test for 30-day results; Mann-Whitney test for
hospital length of stay analysis; and life-table analysis and
Kaplan-Meyer analysis (standard error 10%) using the
log-rank test to compare survival curves for the risk and
symptom groups for long-term follow-up. Statistical signif-
icance was set at an  level of 0.05. Data analysis was
hierarchical. If a patient died and also had a stroke or MI,
only the death was counted. If a patient had both anMI and
a stroke but did not die, then both the stroke and MI were
counted and the person was still coded as experiencing the
event (ie, stroke or MI, or both). Statistical analysis was
performed by Dale Glaser, PhD of Glaser Consulting, San
Diego, California using SPSS software (SPSS Inc, Chicago,
Ill).
RESULTS
Procedure characteristics are shown in Appendix Table II
(available online only). A total of 218 procedures were
performed in men (49%) and 224 in women (51%). The
overall mean age of patients was 73 years (range, 41 to 94
years), and 105 procedures (23.8%) were performed in
patients aged 80 years. CEA was performed on the right
side 216 times (49%) and on the left side 226 times (51%)
for a total of 442 procedures. Patients were symptomatic
before 170 procedures (38.5%) and asymptomatic before
272 procedures (61.5%). Preoperative symptoms consisted
of amaurosis fugax in 19 patients, transient ischemic attack
(TIA) in 84 (including 3 crescendo TIAs), ischemic stroke
in 60, and miscellaneous in 7. Mean ipsilateral stenosis was
80% (range, 50% to 99%), and mean contralateral stenosis
was 33% (range, 0% to 100%). There were 207 high-risk
procedures (46.8%) and 235 standard-risk procedures
(53.2%). Numerous additional risk factors beyond those
defined in SAPPHIRE were identified (Appendix Table III,
available online only).
Patients were taking statins before 195 procedures
(44%) and aspirin before 227 procedures (51%). All pa-
tients were prescribed aspirin postoperatively.
Mean length of stay was 1.59 hospital days, with 355
discharges (80%) occurring the morning after surgery.
There was no statistically significant difference in length of
stay between high-risk and standard-risk patients (P 
0.675).
Of 442 procedures, 439 (99.32%) were treated as in-
tended. General anesthesia was used 442 times (100%), a
shunt was used 441 times (99.8%), a patch was used 440
times (99.5%), and intraoperative completion duplex scan-
ning was performed in 442 procedures (100%). Patch ma-
terial was bovine pericardium in 438 procedures (99%).
During 28 procedures (6.3%), the artery was reopened
because of defects found on an intraoperative completion
duplex scan and the defect was repaired. Defects consistedof 2 instances of missed residual disease in the more prox-
imal common carotid artery, 6 intimal flaps, 7 thrombi, 9
stenoses, and 4 kinks. Three of the four kinked internal
carotid arteries required carotid reconstruction. External
carotid defects were repaired if they caused 30% stenosis.
Follow-up was 100% at 30 days postoperatively. Early
(30 days) adverse events included 1 TIA, 1 minor stroke,
1 major stroke, 1 MI, and no death. The 30-day all strokes
or death rate was 0.45%, and the 30-day all strokes or death
or MI rate was 0.68% (Table II). There were four (0.9%)
temporary cranial nerve injuries (2 vagus, 2 hypoglossal).
There were 20 temporary marginal mandibular nerve defi-
cits and 13 temporary and permanent posterior auricular
nerve deficits. An additional 23 procedures were followed
by mild cervical numbness, indicating injury to small sen-
sory cervical nerves. Hematomas developed after eight pro-
cedures, requiring four returns (0.9%) to surgery. Head-
ache developed in 28 patients, five patients incurred wound
infections, and one patient presented with a temporary,
mild hyperperfusion syndromemanifesting as hypertension
and headache.
Mean long-term follow-up was 31.4 months (range, 1
to 93 months). After 30 days’ follow-up, 13 carotid arteries
developed restenosis of50%, and there were 16 strokes (9
Fig 1. Life-table analysis plot for ipsilateral stroke or death or
myocardial infarction (MI) for the entire cohort.
Table II. Early results (30 days) by risk class (n  442)
Category
Standard
risk
High
risk Total (%) P
All strokes 1 1 2 (0.45) .982
Death 0 0 0 (0) NA
MI 1 0 1 (0.23) .347
All strokes or death 1 1 2 (0.45) .982
All strokes or death
or MI 2 1 3 (0.68) .638
MI, Myocardial infarction; NA, not applicable.ipsilateral), 38 deaths, and 8 MIs. Fig 1 shows the life-table
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 5 Flanigan et al 879plot for composite ipsilateral stroke or death or MI out to
93 months (SE, 0.07 at 93 months). Appendix Table IV
(available online only) shows event-free status at selected
intervals. At the 1-year follow-up, 96% were free of ipsilat-
eral stroke or death or MI.
A 2 analysis of 30-day results demonstrated no statis-
tically significant difference between high-risk and
standard-risk groups for all strokes (P  .928), death (P 
not applicable), MI (P  .347), all strokes or death (P 
.928), or all strokes or death or MI (P  .638; Table II).
There was no statistically significant difference between
asymptomatic and symptomatic patients for all strokes (P
.737), death (PNA), MI (P .429), all strokes or death
(P  .737) or all strokes or death or MI (P  .855; Table
III).
Kaplan-Meyer analysis out to 93 months demonstrated
no statistically significant difference between high-risk and
standard-risk procedures for all strokes (P  .159), ipsilat-
eral stroke (P .350), death (P 0.092), MI (P 0.707),
ipsilateral stroke or death (P .107), or ipsilateral stroke or
death or MI (P  .080; Table IV and Fig 2 [Raw Kaplan-
Meyer data is shown in Appendix Tables V and VI (avail-
able online only)]). Kaplan-Meyer analysis out to 93
months demonstrated no statistically significant difference
between procedures performed in symptomatic vs asymp-
tomatic patients for all strokes (P  .152), death (P 
0.658), MI (P  0.083), ipsilateral stroke or death (P 
.773), or ipsilateral stroke or death or MI (P  0.483).
Fewer ipsilateral strokes were encountered in the symptom-
atic group (P  .043; Table V and Fig 3 [Raw Kaplan-
Meyer data is shown in Appendix Tables VII and VIII
Table III. Early results (30 days) by preoperative
symptom status (n  442)
Category Asymptomatic Symptomatic Total (%) P
All strokes 1 1 2 (0.45) .737
Death 0 0 0 (0) NA
MI 1 0 1 (0.23) .429
All strokes or
death 1 1 2 (0.45) .737
All strokes or
death or MI 2 1 3 (0.68) .855
MI, Myocardial infarction; NA, not applicable.
Table IV. Comparison of high-risk and standard-risk
groups (Kaplan-Meier) during long-term follow-up
Event
High
risk
Standard
risk P
All strokes 10 8 .159
Ipsilateral stroke 6 5 .350
Death 21 17 .092
MI 4 5 .707
Ipsilateral stroke or death 25 22 .107
Ipsilateral stroke or death or MI 28 25 .080
MI, Myocardial infarction.(available online only)]).During follow-up, eight carotid arteries required repeat
ipsilateral CEA (target lesion revascularization [TLR]).
The mean time between procedures was 27 months. Life-
table analysis showed the incidence to be 1% at 1 year and
2% at 2 years. At 93 months, 97% of arteries were free of the
need for TLR (Appendix Fig 1, available online only).
DISCUSSION
The routine use of general anesthesia was associated
with no death and only one MI (0.2%) within the first 30
days. In a series of 3382 CEAs, Rockman et al8 were unable
to demonstrate any difference in morbidity and mortality
when they compared general anesthesia with regional an-
esthesia. Although regional anesthesia may allow earlier
intraoperative detection of cerebral ischemia, the routine
use of shunting in the current series likely negated this
potential advantage. Shunting clearly provides more cere-
bral blood flow than nonshunting, and the use of a T-style
shunt allows for flushing of potential embolic debris that
could result in an intraoperative neurologic deficit. In our
series, no shunt required removal to facilitate exposure, and
Length of Follow Up (months)
100.080.060.040.020.00.0
C
um
 S
ur
vi
va
l f
or
 Ip
si
la
te
ra
l S
tr
ok
e 
or
 D
ea
th
 o
r M
I b
y 
R
is
k 1.0
0.8
0.6
0.4
0.2
0.0
High Risk-censored
Std Risk-censored
High Risk
Std Risk
Survival Functions for Ipsilateral Stroke or Death or MI by Risk
Fig 2. Kaplan-Meier plot comparing ipsilateral stroke or death or
myocardial infarction (MI) by risk stratification. No statistically
significant difference was found between high-risk (green line) and
standard-risk (blue line) groups out to 93 months. Tick marks on
the respective lines show censored data.
Table V. Comparison of symptomatic and asymptomatic
groups (Kaplan-Meier) during long-term follow-up
Event Symptomatic Asymptomatic P
All strokes 4 14 .152
Ipsilateral stroke 1 10 .043
Death 16 22 .658
MI 1 8 .083
Ipsilateral stroke or death 17 30 .773
Ipsilateral stroke or death
or mi 18 35 .483
MI, Myocardial infarction.no embolization through the shunt was documented.
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allows for excellent quality duplex scanning because both
Dacron and polytetrafluoroethylenematerials cause acoustical
shadowing and prevent a complete examination. Patching
clearly requires more time than primary closure but can pre-
vent stenosis, especially at the end point of the endarterec-
tomy, and patching has been shown in a series of 1972
procedures to be associated with a significant reduction in
perioperative stroke compared with primary closure.9 The
increased operative time caused by patching may be moot
when a shunt is routinely used.
In 6.3% of procedures in this series, reopening of the
artery was required to correct technical defects found on
intraoperative duplex scans. It is not possible to know if any
or all of the defects would have led to morbidity if left
uncorrected, but intuitively, it would seem prudent to
complete surgery with the best technical result possible. A
previous study attempted to define which defects require
correcting and which do not.10 To be accurate, this deter-
mination would require a randomized study, but such a
study would have ethical concerns. The surgeon has to use
best judgment to decide which defects to repair because the
reopening of a carotid artery may, in itself, pose an in-
creased risk to the patient. In the current series, all patients
left the operating room with either normal duplex scans or
with duplex scans showing onlyminor defects, as previously
described.10
We combined several surgical techniques previously
shown to have benefit into one procedure yielding a 30-day
composite stroke or death or MI rate of 0.68%. These
results question whether the high-risk group, as defined in
SAPPHIRE, truly represents high-risk patients for CEA. Four
other large studies (2345 CEAs) have also failed to find
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Fig 3. Kaplan-Meier plot comparing ipsilateral stroke or death or
myocardial infarction (MI) by preoperative symptom status. No
statistically significant difference was found between symptomatic
(green) and asymptomatic (blue) groups out to 93 months. Tick
marks on the respective lines show censored data.increased morbidity and mortality for high-risk patients. 4-7The SAPPHIRE study showed a combined stroke or
death or MI rate of 4.8% for carotid stenting and 9.8% for
CEA on an intention-to-treat basis.3 About 71% of patients
in SAPPHIRE were asymptomatic. Two subsequent level 1
studies conducted on standard-risk symptomatic patients,
the Stent-Protected Percutaneous Angioplasty Versus Ca-
rotid Endarterectomy (SPACE) and Endarterectomy Ver-
sus Angioplasty in Patients With Symptomatic Severe Ca-
rotid Stenosis (EVA-3S) trials, yielded distinctly different
results.11,12 The SPACE trial failed to prove noninferiority
of carotid artery stenting compared with CEA for ipsilateral
stroke or death at 30 days (6.84% for stenting vs 6.34% for
CEA). EVA-3S demonstrated a 30-day stroke or death rate
of 3.9% for CEA and 9.6% for carotid stenting.
In the 3500-procedure Carotid ACCULINK/
ACCUNET Post-Approval Trial to Uncover Unantici-
pated or Rare Events (CAPTURE) study of carotid
stents mandated by the FDA, only 13.8% of the patients
were symptomatic.13 In CAPTURE, the 30-day stroke or
death or MI rate in the 482 symptomatic patients was 12.0%,
whereas in Emboshield and Xact Post Approval Carotid Stent
Trial (EXACT) and CAPTURE 2, both postmarket carotid
stent studies subsequent toCAPTURE, that rate improved to
8.6% and 9.1%, respectively.13-15
Bond et al16 recently reviewed 103 reports published
between 1980 and 2000 that stratified risk between symp-
tomatic and asymptomatic patients who had carotid endar-
terectomy and found approximately a 5% stroke and death
rate for symptomatic patients vs a 3% stroke and death rate
in asymptomatic patients. In the current study, no such
difference based on preoperative symptom status was ob-
served.
Stenting appears particularly hazardous in patients
aged 80 years. In CAPTURE, the 30-day stroke or
death or MI rate in symptomatic octogenarians was
17.1%. In the Carotid Revascularization Endarterectomy
vs. Stent Trial (CREST) lead-in phase, including symp-
tomatic and asymptomatic patients, octogenarians under-
going carotid stenting had 30-day stroke or death rate of
12.1%.17 None of the 105 octogenarians in the CEA study
reported here sustained stroke, death, or MI at the 30-day
follow-up.
The Stroke Council of the American Heart Association
advised that a surgeon’s surgical morbidity and mortality
rate should not exceed 3% for asymptomatic patients or 6%
for symptomatic patients.18-20 The pooled data collected
by Bond et al16 indicate that the reported results are in line
with or exceed those recommendations. The 3500 patients
enrolled into the CAPTURE study showed vastly inferior
results for carotid stenting, with a 30-day stroke or death
rate of 4.9% in asymptomatic patients and 10.6% in symp-
tomatic patients.13 The 30-day rate of 0.45% for all strokes
or death in the current study for a specific CEA technique
was vastly superior to that found in CAPTURE and in all of
the other carotid stenting trials as well.
The need for TLR was 3.1% at 2 years and 3.9% at 3
years in the ACCULINK for Revascularization of Carotids
in High-Risk Patients (ARCHER) carotid stenting trial.13
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at 2 years, and 97% were free from the need for TLR at 93
months.
It is possible that the routine measurement of cardiac
enzymes and the performance of routine postoperative
electrocardiograms might have resulted in a higher de-
tection rate for asymptomatic MI in this series. The
1-year death rate after carotid endarterectomy in
SAPPHIRE was 13.5%, whereas in the current study it
was 6% in the high-risk group, suggesting that any
missed asymptomatic MIs in our study did not contrib-
ute to increased mortality.
Routine neurologic examinations by neurologists,
rather than vascular surgeons, might have led to in-
creased detection of minor asymptomatic preoperative
and postoperative neurologic deficits. The low event rate
in this study could have masked differences between the
risk groups, but the current cohort of 442 compares well
with other studies, including SAPPHIRE (n  151
CEAs). Because this study does not randomize our tech-
nique of CEA against other techniques, it is not possible
to conclude with certainty that the good results achieved
in this series are solely due to the surgical technique that
was used.
The current results of carotid stenting neither reach
the level of those attained in this series with a specific
technique of CEA nor those attained in other series of
CEA using a variety of surgical techniques.16 Also, cur-
rent results of carotid stenting suggest the procedure is
too risky in octogenarians and in symptomatic patients.
Nevertheless, carotid stenting most likely will have a role
in specific patients with extracranial cerebrovascular dis-
ease, but those patients are yet to be defined. Future
studies of carotid stenting should consider standardiza-
tion of technique for both stenting and endarterectomy.
It appears unnecessary to limit enrollment of patients
into carotid stenting trials by using the concept of high
surgical risk as previously defined. Liberalizing entry
criteria into stenting trials should facilitate definition of
the role of carotid stenting sooner by providing a larger
data pool for analysis.
CONCLUSIONS
This study demonstrates that the application of a spe-
cific contemporary vascular surgical technique yields excel-
lent short-term and long-term results for CEA and that the
results differ neither between standard-risk vs high-risk
patients (as defined in SAPPHIRE) nor between symptom-
atic vs asymptomatic patients. These data challenge the
concept of a high-risk group of patients for CEA and
suggest entry criteria into carotid stenting trials need not
include high surgical risk as previously defined. Further-
more, this research supports other reports in questioning
whether carotid stenting is appropriate at this time in
symptomatic patients and octogenarians given the excellent
results attained in these groups with CEA.AUTHOR CONTRIBUTIONS
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Volume 46, Number 5 Flanigan et al 882.e1Appendix Table I (online only). Duplex scan criteria
used to determine percent stenosis
Internal Carotid Stenosis % PSV cm/sec
0-15 100
15-49 200
50-60 200-275
70-80 275-350
80-90 350-425
90 425-500
100 0
Appendix Table II (online only). Procedure
characteristics (n  442)
Characteristic No. or mean (range)
Male/female 218/224
Age, y 73 (41-94)
Age 80 105
Symptomatic 170
Asymptomatic 272
Ipsilateral carotid stenosis, % 80 (50-99)
High-risk/standard-risk 207/235
Appendix Table III (online only). Additional
associated risk factors (442 procedures)
Risk factor No. (%)
Angina 18 (4.1)
Dialysis 2 (0.5)
Hypertension 318 (72)
Smoking history 178 (40)
Current smoker 62 (14)
Hyperlipidemia 242 (55)*
Diabetes 102 (23)
*44% were receiving statin therapy.
Appendix Table IV (online only). Proportion free of
ipsilateral stroke and death and myocardial infarction at
selected intervals (life table)
Interval (m) Proportion event free, % SE
6 98 .01
12 96 .01
24 97 .02
36 89 .02
48 82 .03
60 77 .04
72 68 .05
84 60 .07
SE, standard error.
Appendix Table V (online only). Kaplan-Meyer table for ipsilateral stroke or death or MI (SDMI) by risk status
Life Table
First-order Controls
Interval
Start
Time
Number
Entering
Interval
Number
Withdrawing
during
Interval
Number
Exposed
to Risk
Number
of
Terminal
Events
Proportion
Terminating
Proportion
Surviving
Cumulative
Proportion
Surviving
at End of
Interval
Std. Error
of
Cumulative
Proportion
Surviving
at End of
Interval
Probability
Density
Std. Error
of
Probability
Density
Hazard
Rate
Std.
Error of
Hazard
Rate
High Risk 0 Std
Risk
.000 235 33 218.500 2 .01 .99 .99 .01 .002 .001 .00 .00
High Risk 6.000 200 15 192.500 1 .01 .99 .99 .01 .001 .001 .00 .00
12.000 184 18 175.000 2 .01 .99 .97 .01 .002 .001 .00 .00
18.000 164 25 151.500 3 .02 .98 .96 .02 .003 .002 .00 .00
24.000 136 13 129.500 4 .03 .97 .93 .02 .005 .002 .01 .00
30.000 119 11 113.500 1 .01 .99 .92 .02 .001 .001 .00 .00
36.000 107 19 97.500 1 .01 .99 .91 .02 .002 .002 .00 .00
42.000 87 17 78.500 2 .03 .97 .88 .03 .004 .003 .00 .00
48.000 68 12 62.000 2 .03 .97 .86 .03 .005 .003 .01 .00
54.000 54 9 49.500 1 .02 .98 .84 .04 .003 .003 .00 .00
60.000 44 13 37.500 3 .08 .92 .77 .05 .011 .006 .01 .01
66.000 28 9 23.500 0 .00 1.00 .77 .05 .000 .000 .00 .00
72.000 19 5 16.500 2 .12 .88 .68 .08 .016 .010 .02 .02
78.000 12 5 9.500 1 .11 .89 .61 .10 .012 .011 .02 .02
84.000 6 3 4.500 0 .00 1.00 .61 .10 .000 .000 .00 .00
90.000 3 3 1.500 0 .00 1.00 .61 .10 .000 .000 .00 .00
1 High Risk .000 207 40 187.000 3 .02 .98 .98 .01 .003 .002 .00 .00
6.000 164 16 156.000 4 .03 .97 .96 .02 .004 .002 .00 .00
12.000 144 12 138.000 3 .02 .98 .94 .02 .003 .002 .00 .00
18.000 129 13 122.500 2 .02 .98 .92 .02 .003 .002 .00 .00
24.000 114 15 106.500 4 .04 .96 .89 .03 .006 .003 .01 .00
30.000 95 17 86.500 2 .02 .98 .87 .03 .003 .002 .00 .00
36.000 76 14 69.000 3 .04 .96 .83 .04 .006 .004 .01 .00
42.000 59 11 53.500 3 .06 .94 .78 .04 .008 .004 .01 .01
48.000 45 12 39.000 0 .00 1.00 .78 .04 .000 .000 .00 .00
54.000 33 10 28.000 1 .04 .96 .76 .05 .005 .005 .01 .01
60.000 22 7 18.500 2 .11 .89 .67 .07 .014 .009 .02 .01
66.000 13 6 10.000 1 .10 .90 .61 .09 .011 .011 .02 .02
72.000 6 2 5.000 0 .00 1.00 .61 .09 .000 .000 .00 .00
78.000 4 1 3.500 0 .00 1.00 .61 .09 .000 .000 .00 .00
84.000 3 3 1.500 0 .00 1.00 .61 .09 .000 .000 .00 .00
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Case Processing Summary
HighRisk
HighRisk Total N N of Events
Censored
N Percent
0 Std Risk 235 25 210 89.4%
1 High Risk 207 28 179 86.5%
Overall 442 53 389 88.0%
Means and Medians for Survival Time
HighRisk
HighRisk
Meana Median
Estimate Std. Error
95% Confidence Interval
Estimate Std. Error
95% Confidence Interval
Lower Bound Upper Bound Lower Bound Upper Bound
0 Std Risk 79.018 2.580 73.962 84.074 — — — —
1 High Risk 70.012 2.747 64.627 75.397 — — — —
Overall 76.738 2.086 72.650 80.827 — — — —
Percentiles
HighRisk
HighRisk
25.0% 50.0% 75.0%
Estimate Std. Error Estimate Std. Error Estimate Std. Error
0 Std Risk — — — — 73.167 6.022
1 High Risk — — — — 61.633 7.693
Overall — — — — 64.800 5.235
aEstimation is limited to the largest survival time if it is censored.
Appendix Table VII (online only). Kaplan-Meyer table for ipsilateral stroke or death, or MI (SDMI) by symptom status
Life Table
First-order Controls
Interval
Start
Time
Number
Entering
Interval
Number
Withdrawing
During
Interval
Number
Exposed
to Risk
Number
of
Terminal
Events
Proportion
Terminating
Proportion
Surviving
Cumulative
Proportion
Surviving
at End of
Interval
Std. Error
of
Cumulative
Proportion
Surviving
at End of
Interval
Probability
Density
Std. Error
of
Probability
Density
Hazard
Rate
Std.
Error of
Hazard
Rate
asymptot_num .00
asymptomatic
.000 272 42 251.000 3 .01 .99 .99 .01 .002 .001 .00 .00
6.000 227 19 217.500 4 .02 .98 .97 .01 .003 .002 .00 .00
12.000 204 16 196.000 4 .02 .98 .95 .01 .003 .002 .00 .00
18.000 184 25 171.500 4 .02 .98 .93 .02 .004 .002 .00 .00
24.000 155 18 146.000 5 .03 .97 .90 .02 .005 .002 .01 .00
30.000 132 17 123.500 1 .01 .99 .89 .02 .001 .001 .00 .00
36.000 114 23 102.500 3 .03 .97 .86 .03 .004 .002 .00 .00
42.000 88 19 78.500 3 .04 .96 .83 .03 .005 .003 .01 .00
48.000 66 15 58.500 1 .02 .98 .82 .03 .002 .002 .00 .00
54.000 50 10 45.000 2 .04 .96 .78 .04 .006 .004 .01 .01
60.000 38 11 32.500 2 .06 .94 .73 .05 .008 .005 .01 .01
66.000 25 7 21.500 0 .00 1.00 .73 .05 .000 .000 .00 .00
72.000 18 6 15.000 2 .13 .87 .63 .08 .016 .011 .02 .02
78.000 10 5 7.500 1 .13 .87 .55 .10 .014 .013 .02 .02
84.000 4 3 2.500 0 .00 1.00 .55 .10 .000 .000 .00 .00
90.000 1 1 .500 0 .00 1.00 .55 .10 .000 .000 .00 .00
1.00 symptomatic .000 170 31 154.500 2 .01 .99 .99 .01 .002 .002 .00 .00
6.000 137 12 131.000 1 .01 .99 .98 .01 .001 .001 .00 .00
12.000 124 14 117.000 1 .01 .99 .97 .01 .001 .001 .00 .00
18.000 109 13 102.500 1 .01 .99 .96 .02 .002 .002 .00 .00
24.000 95 10 90.000 3 .03 .97 .93 .02 .005 .003 .01 .00
30.000 82 11 76.500 2 .03 .97 .91 .03 .004 .003 .00 .00
36.000 69 10 64.000 1 .02 .98 .89 .03 .002 .002 .00 .00
42.000 58 9 53.500 2 .04 .96 .86 .04 .006 .004 .01 .00
48.000 47 9 42.500 1 .02 .98 .84 .04 .003 .003 .00 .00
54.000 37 9 32.500 0 .00 1.00 .84 .04 .000 .000 .00 .00
60.000 28 9 23.500 3 .13 .87 .73 .07 .018 .010 .02 .01
66.000 16 6 12.000 1 .08 .92 .67 .09 .010 .010 .01 .01
72.000 7 1 6.500 0 .00 1.00 .67 .09 .000 .000 .00 .00
78.000 6 1 5.500 0 .00 1.00 .67 .09 .000 .000 .00 .00
84.000 5 3 3.500 0 .00 1.00 .67 .09 .000 .000 .00 .00
90.000 2 2 1.000 0 .00 1.00 .67 .09 .000 .000 .00 .00
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Case Processing Summary
asymptot_num Total N N of Events
Censored
N Percent
.00 asymptomatic 272 35 237 87.1%
1.00 symptomatic 170 18 152 89.4%
Overall 442 53 389 88.0%
Means and Medians for Survival Time
asymptot_num
Meana Median
Estimate Std. Error
95% Confidence Interval
Estimate Std. Error
95% Confidence Interval
Lower Bound Upper Bound Lower Bound Upper Bound
.00 asymptomatic 75.399 2.766 69.977 80.822 — — — —
1.00 symptomatic 78.289 3.073 72.266 84.311 — — — —
Overall 76.738 2.086 72.650 80.827 — — — —
Percentiles
asymptot_num
25.0% 50.0% 75.0%
Estimate Std. Error Estimate Std. Error Estimate Std. Error
.00 asymptomatic — — — — 65.567 9.271
1.00 symptomatic — — — — 64.800 7.822
Overall — — — — 64.800 5.235
aEstimation is limited to the largest survival time if it is censored.
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November 2007882.e6 Flanigan et alAppendix Fig 1. (online only). Life-table plot of target lesion
revascularization (TLR). At 93 months postoperatively, 97% of
arteries were free from TLR.
